Spartan Bio, TrimGen Sign Development, Distribution Pact | GenomeWeb
NEW YORK (GenomeWeb News) – Under a new strategic partnership, TrimGen will develop technology for Spartan Bioscience and Spartan will distribute TrimGen products in Canada, Ottawa-based Spartan said today.
 
TrimGen has agreed to develop real-time PCR reagents and kits for the Spartan DX device. Coupling the Spartan DX with TrimGen’s real-time PCR assays allows Spartan to offer “a complete solution for rapid DNA testing,” Spartan Bioscience CEO Paul Lem said in a statement.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.